{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "binds",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P16070",
      "entity_text" : "CD44",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "interpro:IPR001759",
      "entity_text" : "PTX",
      "entity_type" : "family"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0971" ],
      "Organ" : [ "uberon:UBERON:0000468" ],
      "CellType" : [ "cl:CL:0000235" ],
      "Species" : [ "taxonomy:10090" ]
    }
  },
  "verbose_text" : "HA-SLNs / PTX bind specifically to CD44, allowing targeting of cancer stem like cells, efficient receptor mediated endocytosis and potent antitumor activity.",
  "reading_complete" : "2020-08-03T10:09:22Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T10:07:29Z",
  "trigger" : "bind",
  "evidence" : [ "PTX bind specifically to CD44" ],
  "pmc_id" : "4402499",
  "score" : 0
}